Skip to main content

Day: July 8, 2022

OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides Business Update

Preliminary Total Revenue for Q2 2022 was approximately $1.0 million Cash as of June 30, 2022 was approximately $16.6 million First commercial customer contract for Acuitas AMR Gene Panel signed in June 2022ROCKVILLE, Md., July 08, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that total preliminary unaudited revenue for the second quarter of 2022 was approximately $1.0 million, up from $0.8 million in the second quarter of 2021. Cash as of June 30, 2022 was approximately $16.6 million. The company announced accomplishment of the following key milestones and recent developments in the second quarter:OpGen signed its first commercial customer contract for the Acuitas...

Continue reading

Enact to Host Second Quarter 2022 Earnings Call August 2nd

RALEIGH, N.C., July 08, 2022 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its second quarter earnings release after the market closes on August 1, 2022. Enact will host a conference call to review second quarter 2022 financial results on August 2, 2022 at 8:00 a.m. (ET). Enact’s earnings release, summary presentation and financial supplement will be available through the company’s website, https://ir.enactmi.com/, at the time of their release to the public. Enact’s conference call can be accessed via telephone and Internet. The dial-in number for Enact’s August 2nd conference call is 866-634-2594 or 412-902-4104 (outside the U.S.); participants should ask to be joined into the Enact Holdings, Inc. call. To participate in the call by webcast, register at https://ir.enactmi.com/news-and-events/events...

Continue reading

SIGA Technologies Receives Approval from UK for Tecovirimat

Treatment Approved for Smallpox, Monkeypox, Cowpox, and Vaccinia Complications NEW YORK, July 08, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the United Kingdom has approved SIGA’s oral tecovirimat (known in the U.S. as oral TPOXX) for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in adults and children with a body weight of at least 13kg. “We are very pleased that the UK has taken this important step in health emergency preparedness, not just for the immediate need in the current monkeypox outbreak, but for broader readiness by approving tecovirimat for treatment for a wide range of uses,” said Dr. Phil Gomez, CEO of SIGA. “As we have...

Continue reading

Kymera Therapeutics Strengthens Board of Directors with Appointment of People and Business Leader Leigh Morgan

WATERTOWN, Mass., July 08, 2022 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Leigh Morgan to its Board of Directors. Ms. Morgan joins Kymera’s Board as a senior executive accomplished in scaling global, profitable, high-performing organizations. “Leigh has distinguished herself as an expert in developing world-class organizations in a wide variety of settings, and I’m thrilled to welcome her to Kymera’s Board of Directors,” said Nello Mainolfi, PhD, Co-Founder, President and Chief Executive Officer of Kymera Therapeutics. “Given our aspirations to evolve Kymera into a fully-integrated, global biopharmaceutical company, her extensive background...

Continue reading

Healthcare Realty Trust Reports Progress on Asset Sales and Joint Venture Transactions

Both ISS and Glass Lewis recommend that Healthcare Realty shareholders vote “FOR” the transaction with HTA at upcoming July 15 special meeting NASHVILLE, Tenn., July 08, 2022 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE: HR) (“Healthcare Realty” or the “Company”) today provided an update regarding its strategic combination with Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”). As previously announced, the transaction consideration includes a stock exchange ratio of 1:1 and a special cash dividend of $4.82 per share to HTA shareholders which totals $1.1 billion. The Company expects to fund the $1.1 billion special cash dividend to HTA shareholders through a combination of asset sales and joint venture transactions at a blended cap rate of 4.8%. Proceeds are expected to be derived from properties under contract...

Continue reading

Endeavour Silver Reports Strong Q2 2022 Production Results; Higher Grades at the Guanacevi Mine Drive Strong Operational Performance

VANCOUVER, British Columbia, July 08, 2022 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to report second quarter 2022 production of 1,359,207 silver ounces (oz) and 9,289 gold oz, for silver equivalent1 (“AgEq”) production of 2.1 million oz. Production continues to outpace the 2022 production guidance of 6.7-7.6 million silver equivalent ounces, totaling 4.1 million AgEq oz for the six months ended June 30, 2022. “Amid ongoing turmoil in the markets due to supply constraints, continued inflation concerns, and uncertainty from the raising of interest rates from historical lows, we had another solid quarter of production” stated Dan Dickson, Chief Executive Officer. “Despite the current macro trends, the Company and precious metals outlook remains optimistic. Given our...

Continue reading

Mineworx Announces Rights Offering and Share Consolidation

EDMONTON, Alberta, July 08, 2022 (GLOBE NEWSWIRE) — Mineworx Technologies Ltd., (the “Company” or “Mineworx“) (TSXV: MWX) (OTCQB: MWXRF) (FSE: YRS WKN: A2DSW3) announced that it will be offering rights (the “Rights Offering“) to holders of its common shares (“Common Shares“) of record at the close of business on July 18, 2022 (the “Record Date”). Pursuant to the Rights Offering, each holder of Common Shares (a “Shareholder”) will receive one (1) transferable right (each, a “Right”) for each Common Share held as of the Record Date. One (1) Right will entitle the holder thereof to subscribe for one Common Share upon payment of the subscription price of $0.015 per Common Share until 5:00 p.m. (Toronto time) (the “Expiry Time”) on September 12, 2022. Assuming the exercise of all Rights, the Rights Offering will...

Continue reading

Aurora Mobile’s Subsidiary SendCloud Partners with Ding Xiang Yuan to Jointly Enhance Customer Reach

SHENZHEN, China, July 08, 2022 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary Wuhan SendCloud Technology Co., Ltd. (“SendCloud”) has entered into a strategic partnership with Guanlan Networks (Hangzhou) Co., Ltd., the operator of Ding Xiang Yuan, a leading digital medical service platform in China. Leveraging its years of technical expertise and experience in email services, SendCloud will help Ding Xiang Yuan optimize and expand its customer reach. This partnership is a testament to SendCloud’s leading position and strong capabilities in email and SMS messaging services. Through professional content sharing, active user interaction, extensive accumulation of medical...

Continue reading

Form 8.3 – [CARETECH HOLDINGS PLC – 07 07 2022] CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

PKN ORLEN and KN establish cooperation in the field of offshore wind energy

KN (Klaipėdos Nafta AB), the operator of oil and liquefied natural gas (LNG) terminals, and the companies of the largest Polish oil group ORLEN, ORLEN Neptun I and Energa Wytwarzanie, signed a letter of intent on the possibility of cooperation in the provision of operation and maintenance (O&M) services for wind farms in the Baltic Sea. The letter of intent sets out an agreement on the synergy and conditions for cooperation between the three parties in the development and implementation of an O&M strategy for wind farms in the Lithuanian part of the Baltic Sea. Initially, the O&M strategy for wind farms is foreseen to be developed for the possible operation of two wind farms in the Lithuanian part of the Baltic Sea, and if successful, the cooperation would expand to cover more projects. The strategy is expected to be ready...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.